SecBot SecBot
SECBOTREPLAY Home › Report › IMA

IMA · ImageneBio (IMA) announced a $30 million private placement led by…

ImageneBio, Inc. · PRESS-RELEASE filed Apr 13, 2026 at 07:00 ET

At the news

BEARISHIMPACT 6/10

PRESS-RELEASE filed Apr 13, 2026 at 07:00 ET

ImageneBio (IMA) announced a $30 million private placement led by Coastlands Capital, with proceeds aimed at advancing its IMG-007 program in alopecia areata and atopic dermatitis. The offering includes pre-funded warrants exercisable at $0.001 per share, representing immediate economic dilution to existing shareholders.

  • ImageneBio raised approximately $30 million in a private placement through pre-funded warrants.
  • Pre-funded warrants for 5,770,335 shares were sold at $5.199 per unit, exercisable at $0.001 per share.
  • Proceeds will fund development of IMG-007 in alopecia areata and late-stage atopic dermatitis trials.
  • The placement was led by new investor Coastlands Capital, with participation from Trails Edge Capital, Omega Funds, and OrbiMed.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access